Sponsor pipeline

Beijing BeneWill Technology Development Co., Ltd clinical trial pipeline

Get alerts when Beijing BeneWill Technology Development Co., Ltd's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

First postedNew trial filingPhaseStatus
2026-10-06 NCT07860216 Phase III Clinical Trial of Recombinant Respiratory Syncytial Virus Vaccine (CHO Cells) Phase 3 Recruiting

Active trials by phase

Phase 3
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT07860216 Phase III Clinical Trial of Recombinant Respiratory Syncytial Virus Vaccine (CHO Cells) Assessing the Effectiveness of Vaccines in Preventing Adult RSV-caused Lower Respiratory Tract Disease (LRTD) Recruiting 2026-10-06
Get alerts when Beijing BeneWill Technology Development Co., Ltd's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free